ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!HRTX Company Profile and Key Details
Heron Therapeutics, Inc.
HRTX Stock Price Chart
Stock Price Today
Heron Therapeutics, Inc. (HRTX) stock declined over -9.31%, trading at $2.24 on NASDAQ, down from the previous close of $2.47. The stock opened at $2.42, fluctuating between $2.21 and $2.48 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; HTX-019, an investigational agent for the prevention of postoperative nausea and vomiting; and HTX-034 for postoperative pain management, as well as is in Phase Ib/II clinical study in patients undergoing bunionectomy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.
Company Information
| Employees | 126 |
| Beta | 1.61 |
| Sales or Revenue | $127.04M |
| 5Y Sales Change% | -0.131% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Heron Therapeutics, Inc. (NASDAQ: HRTX) stock price is $2.24 in the last trading session. During the trading session, HRTX stock reached the peak price of $2.48 while $2.21 was the lowest point it dropped to. The percentage change in HRTX stock occurred in the recent session was -9.31% while the dollar amount for the price change in HRTX stock was -$0.23.
The NASDAQ listed HRTX is part of Biotechnology industry that operates in the broader Healthcare sector. Heron Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Michael E. Mathews
Senior Vice President of Acute Care
Dr. Barry D. Quart Pharm.D.
Chairman & Chief Executive Officer
Mr. David L. Szekeres
Executive Vice President & Chief Operating Officer
Dr. Chris M. Storgard
Chief Medical Officer
Dr. Thomas B. Ottoboni Ph.D.
Chief Scientific Officer and Senior Vice President of Pharmaceutical & Translational Sciences
Mr. Sean T. Ristine
Senior Vice President of HR
Ms. Kimberly J. Manhard
Executive Vice President of Drug Devel.
Mr. Craig Alexander Collard
Chief Executive Officer & Director
Ms. Lisa Peraza
Vice President & Chief Accounting Officer
Mr. Robert Sullivan
Senior Vice President of Oncology Care Franchise & Commercial Operations
Dr. William P. Forbes Pharm. D., Pharm.D.
Executive Vice President & Chief Devel. Officer
Ms. Ira Duarte
Executive Vice President & Chief Financial Officer
Mr. John W. Poyhonen
Pres & Chief Commercial Officer
HRTX's closing price is 115.39% higher than its 52-week low of $1.04 where as its distance from 52-week high of $3.93 is -43%.
Number of HRTX employees currently stands at 126.
Official Website of HRTX is: https://www.herontx.com
HRTX could be contacted at phone 858 251 4400 and can also be accessed through its website. HRTX operates from 4242 Campus Point Court, San Diego, CA 92121, United States.
HRTX stock volume for the day was 3.23M shares. The average number of HRTX shares traded daily for last 3 months was 3.13M.
The market value of HRTX currently stands at $340.69M with its latest stock price at $2.24 and 152.1M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com